Does the Geko nerve stimulator reduce Deep Vein Thrombosis (DVT) and improve healing in ankle fractures?

A randomised controlled trial investigating the effect of the Geko nerve stimulator to reduce DVT rates and improve healing in ankle fractures

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN95441725

Enrollment

400

Registered

2013-01-07

Start date

2012-11-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle fracture Injury, Occupational Diseases, Poisoning Fractures of other parts of lower leg

Interventions

Each patient randomised into one of two groups i.e. those who receive the stimulator for a two week period post operative period and those who do not. The treatment of patients will not be affected

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or older, either sex 2. Patients with closed ankle fractures that have required open reduction and internal fixation 3. Patients who are able to consent for themselves

Exclusion criteria

Exclusion criteria: 1. Open fractures 2. Diabetics 3. Those with peripheral neuropathy, metabolic bone disorders and immunological disorders 4. Patients undergoing revision procedures 5. Patients with syndesmotic injury requiring screw removal prior to mobilisation 6. Those unable to use the Geko device

Design outcomes

Primary

Measure	Time frame
1. DVT rate 2. Time to Union	—

Secondary

Measure	Time frame
1. Manchester - Oxford Foot and ankle questionnaire at end of 3 months 2. Time to return work	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026